Effects of clozapine on sleep: A longitudinal study

Biological Psychiatry

Volumn 42, Issue 4, 1997, Pages 260-266

  Hinze Selch, Dunja ^a   Mullington, Janet ^a   Orth, Armin ^a   Lauer, Christoph J ^a   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

antipsychotic agents; clozapine; non REM sleep; REM sleep; schizophrenia; sleep

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; MALE; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SCHIZOPHRENIA; SEDATION; SLEEP;

ADULT; ANTIPSYCHOTIC AGENTS; BODY TEMPERATURE; CLOZAPINE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SLEEP; SLEEP, REM;

EID: 0030790714     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00347-2     Document Type: Article

References (38)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
2. Angst J, Bente D, Berner P, Heimann H, Helmchen H, Hippius H (1971): Das klinische Wirkungsbild von Clozapin (Untersuchung mit dem AMP-System). Pharmakopsychiatrie 13: 201-211.
3. Baldessarini RJ, Frankenburg FR (1991): Clozapine, a novel antipsychotic agent. N Engl J Med 324:746-754.
4. Bauer J, Hohagen F, Gimmel E, et al (1995): Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry 38:611-621.
5. Blum A, Girke W (1973): Marked increase in REM sleep produced by a new antipsychotic compound. Clin Electrophysiol 4:80-84.
6. Blum A, Mauruschat W (1972): Temperaturanstiege und Bluteiweissveränderungen unter der Therapie mit Neuroleptika -unter besonderer Berücksichtigung des neuartigen Dibenzodiazepin-Derivates Clozapin. Pharmakopsychiatrie 5:155-169.
7. Coward DM (1992): General pharmacology of clozapine. Br J Psychiatry 160(suppl 17):5-11.
8. Driver HS, Flanigan MJ, Bentley AJ, Luus HG, Shapiro CM, Mitchell D (1995): The influence of ipsaspirone, a 5-HT1A agonist, on sleep patterns of healthy subjects. Psychopharmacology 117:186-192.
9. Farde L, Nordström AL (1992): PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry 160(suppl 17):30-33.
10. Farde L, Nordström AL, Nyberg S, Halldin C, Sedvall G (1994): D1-, D2-and 5-HT-receptor occupancy in clozapine treated patients. J Clin Psychiatry 55(9, suppl B):67-69.
11. Gillin JC, Post RM, Wyatt RJ, Goodwin FK, Snyder F, Bunney WE Jr (1973): REM inhibitory effect of L-dopa infusion during human sleep. Electroencephalogr Clin Neurophysiol 35:181-186.
12. Gillin JC, Salin-Pascual R, Velazquez-Moctezume J, Shiromani P, Zoltoski R (1993): Cholinergic receptor subtypes and REM sleep in animals and normal controls. Prog Brain Res 98:379-387.
13. Hinze-Selch D, Mullington J, Pollmächer T (1995): Sleep during clozapine-induced fever in a schizophrenic patient. Biol Psychiatry 38:690-693.
14. Hobson JA, Datta S, Calvo JM, Quattrochi J (1993): Acetylcholine as a brain state modulator: Triggering and long-term regulation of REM sleep. Prog Brain Res 98:389-404.
15. Horne JA, Reid AJ (1985): Night-time sleep EEG changes following body heating in a warm bath. Electroencephalogr Clin Neurophysiol 60:154-157.
16. Horne JA, Staff LHE (1983): Exercise and sleep: Body-heating effects. Sleep 6:36-46.
17. Karacan I, Wolff SM, Williams RL, Hursch CJ, Webb WB (1968): The effects of fever on sleep and dream patterns. Psychosomatics 9:331-339.
18. Korth C, Mullington J, Schreiber W, Pollmächer T (1996): Influence of endotoxin on daytime sleep in humans. Infect Immun 64:1110-1115.
19. Lauer CJ, Riemann D, Wiegand M, Berger M (1991): From early to late adulthood: Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 29:979-993.
20. Lauer CJ, Schreiber W, Pollmächer T, Holsboer F, Krieg JC (in press): Sleep in schizophrenia: A polysomnographic study on drug-naive patients. Neuropsychopharmacology.
21. Mason SL, Reynolds GP (1992): Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue. Eur J Pharmacol 221:397-398.
22. Meltzer HY (1994): An overview of the mechanism of action of clozapine. J Clin Psychiatry 55(9, suppl B):47-52.
23. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M (1993): Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 266:726-731.
24. Overall JE, Gorham DR (1962): The brief psychiatric rating scale. Psychol Rep 10:799-812.
25. Pollmächer T, Schreiber W, Gudewill S, et al (1993): Influence of endotoxin on nocturnal sleep in humans. Am J Physiol 264:R1077-R1083.
26. Pollmächer T, Mullington J, Korth C, Hinze-Selch D (1995): Influence of host defense activation on sleep in humans. Adv Neuroimmunol 5:155-169.
27. Pollmächer T, Hinze-Selch D, Mullington J (in press): Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol.
28. Rechtschaffen A, Kales A (eds) (1968): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: National Institute of Neurological Diseases and Blindness.
29. Riemann D, Hohagen F, Fleckenstein P, Schredl M, Berger M (1991): The cholinergic REM induction test with RS86 after scopolamine pretreatment in healthy subjects. Psychiatry Res 38:247-260.
30. Rüther E, Davis L, Papousek M, Reichinger M, Reiter H, Rudolph M (1976): Pharmakologische Beeinflussung zentraler serotonerger Mechanismen am Menschen und Auswirkung auf den Schlaf. Drug Res 26:1071-1073.
31. Shoham S, Davenne D, Cady AB, Dinarello CA, Krueger JM (1987): Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253:R142-R149.
32. Spierings ELH, Dzoljic MR, Godschalk M (1977): Effect of clozapine on the sleep pattern in the rat. Pharmacology 15:551-556.
33. Stutzmann JM, Eon B, Lucas M, Blanchard JC, Laduron PM (1992): RP 62203, a 5-hydroxytryptamine 2 antagonist, enhances deep NREM sleep in rats. Sleep 15:119-124.
34. Tandon R, Kane JM (1993): Neuropharmacologic basis for clozapine's unique profile. Arch Gen Psychiatry 50:158-159.
35. Tandon R, Shipley J, Taylor S, Goodson JA, Greden JF (1995): Effects of clozapine on sleep-EEG measures in schizophrenia. Schizophr Res 15:167.
36. Touyz SW, Beumont PJV, Saayman GS, Zabow T (1977): A psychophysiological investigation of the short-term effects of clozapine upon sleep parameters of normal young adults. Biol Psychiatry 12:801-822.
37. van der Poll T, Lowry SF (1995): Tumor necrosis factor insepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3:1-12.
38. Wetter TC, Lauer CJ, Gillich G, Pollmächer T (in press): The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res.